Esomeprazole Magnesium Capsule, Delayed Release
Product Images NDC 60687-934

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Esomeprazole Magnesium (NDC 60687-934). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by American Health Packaging, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

20 mg Esomeprazole Magnesium Dr Capsule Blister.jpg (20 mg Esomeprazole Magnesium Dr Capsule Blister)

20 mg Esomeprazole Magnesium Dr Capsule Blister.jpg (20 mg Esomeprazole Magnesium Dr Capsule Blister)
Label sheet containing multiple identical labels for Esomeprazole Magnesium 20 mg delayed-release capsules. Each label includes the drug name, dosage form, strength, lot number, expiration date (2025-12-01), labeler American Health Packaging, and barcode. Labels are arranged in pairs on each row.*
FDA Label Image

20 mg Esomeprazole Magnesium Dr Capsules Carton.jpg (20 mg Esomeprazole Magnesium Dr Capsules Carton)

20 mg Esomeprazole Magnesium Dr Capsules Carton.jpg (20 mg Esomeprazole Magnesium Dr Capsules Carton)
Esomeprazole Magnesium 20 mg delayed-release capsules label from American Health Packaging. The label shows 30 capsules (3 x 10) with instructions for pharmacists to dispense with medication guides. Storage conditions and related prescription information are also included, along with a barcode and QR code for medication guide and prescribing information.*
FDA Label Image

Ahp93421

Ahp93421
Esomeprazole Magnesium 20 mg delayed-release capsule for oral use. The capsule is white and has the imprint 'H E2' on one side. It is labeled by American Health Packaging.*
FDA Label Image

Esomeprazolemagnesiumfigure1 (Esomeprazolemagnesiumfigure1)

Esomeprazolemagnesiumfigure1 (Esomeprazolemagnesiumfigure1)
Chemical structure diagram of esomeprazole magnesium trihydrate showing the molecular arrangement including aromatic rings, nitrogen, sulfur, magnesium ion, and water molecules.*
FDA Label Image

Figure 2 (Figure 2)

Figure 2 (Figure 2)
A line graph showing percent maintained over a 6-month period for Esomeprazole Magnesium delayed-release capsules at 40 mg, 20 mg, 10 mg, and placebo groups. The y-axis represents percent maintained from 0 to 100, and the x-axis represents months from 0 to 6. The graph compares the maintenance rates for each dosage and placebo over time.*
FDA Label Image

Figure 3 (Figure 3)

Figure 3 (Figure 3)
A line graph depicting the percentage maintained over six months for Esomeprazole Magnesium delayed-release capsules at 10 mg, 20 mg, 40 mg doses, and placebo. The y-axis shows percent maintained from 0 to 100, and the x-axis represents months from 0 to 6. Four lines track data points, showing higher maintenance at 40 mg and 20 mg doses compared to 10 mg and placebo.*
FDA Label Image

Figure 4 (Figure 4)

Figure 4 (Figure 4)
A line graph comparing the percentage of patients symptom-free over 28 days among three groups: Esomeprazole Magnesium Delayed-Release Capsules 40 mg, Esomeprazole Magnesium Delayed-Release Capsules 20 mg, and placebo. The y-axis shows percent of patients symptom-free from 0 to 100, and the x-axis represents diary days from 0 to 28.*
FDA Label Image

Figure 5 (Figure 5)

Figure 5 (Figure 5)
A line graph showing the percentage of patients symptom-free over 28 diary days. It compares Esomeprazole Magnesium delayed-release capsules 40 mg and 20 mg with placebo, with the 20 mg dose showing a slightly higher percentage of symptom-free patients than 40 mg, both outperforming placebo consistently.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.